EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical Use of Hypertonic Lactate—Current Evidence and Emerging Perspectives

Mette Glavind Bülow Pedersen iD, Jens Hohwü Voigt, Esben Søndergaard iD, Niels Møller iD, Nikolaj Rittig iD

The Journal of Clinical Endocrinology & Metabolism · 07.08.2025 · 110 (9) · e2845-e2851

DOI: 10.1210/clinem/dgaf321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 29.05.2025. Verfasst von Mette Glavind Bülow Pedersen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Medical/Steno Aarhus Research Laboratory, Aarhus University, Aarhus N DK-8200, Denmark. Hauptthemen laut MEDLINE: Sodium Lactate, Lactic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Lactate has traditionally been viewed as a metabolic byproduct associated with metabolic acidosis, exercise-induced fatigue, and cancer metabolism. However, accumulating evidence highlights its valuable role as an alternative fuel and a key signaling molecule. Hypertonic sodium lactate infusions have gained interest for their potential therapeutic applications, particularly in neurology and cardiology. This review examines the established and potential clinical uses of exogenous hypertonic lactate treatment. Evidence Acquisition A literature search was conducted in PubMed and Medline using the following keywords: hypertonic lactate, half-molar sodium lactate, sodium lactate, and exogenous lactate. The search was limited to human studies investigating hypertonic sodium lactate solutions with a lactate concentration ≥500 mmol/L as an intervention. Case reports, pediatric studies, preclinical research, and studies in psychiatric populations were excluded. Evidence Synthesis Infusion of hypertonic lactate has demonstrated promising effects across several clinical settings, serving as an alternative fuel for the brain that supports up to 20% of cerebral energy metabolism. In patients with traumatic brain injury, lactate treatment increases cerebral glucose availability, reduces intracranial pressure, and enhances cognitive recovery. In the heart, lactate infusion increases cardiac output, stroke volume, and ejection fraction, potentially benefiting heart failure patients. Hypertonic lactate infusions are generally well tolerated, with minor electrolyte changes as the most common side effect.

Conclusion

Lactate is emerging as a therapeutic agent beyond its traditional role in metabolism. Hypertonic sodium lactate infusions have potential therapeutic benefits within neurology and cardiology, but large-scale trials are required to evaluate efficacy, optimize dosing, and assess long-term safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium LactateLactic AcidHumansHypertonic SolutionsEnergy Metabolism

Stichwörter der Autor:innen

clinical applicationhypertonic lactatesodium lactate

Substanzen

Sodium LactateLactic AcidHypertonic Solutions

Autor:innen und Institutionen

  • Department of Clinical Medicine, Medical/Steno Aarhus Research Laboratory, Aarhus University, Aarhus N DK-8200, Denmark.
  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N DK-8200, Denmark.

ORCID-Profile: Mette Glavind Bülow Pedersen, Esben Søndergaard, Niels Møller, Nikolaj Rittig

Förderung

  • Novo Nordisk Foundation

Zitieren

APA

Pedersen, M. G. B., Voigt, J. H., Søndergaard, E., Møller, N., & Rittig, N. (2025). Clinical Use of Hypertonic Lactate—Current Evidence and Emerging Perspectives. The Journal of Clinical Endocrinology & Metabolism, 110(9), e2845-e2851. https://doi.org/10.1210/clinem/dgaf321

Vancouver

Pedersen MGB, Voigt JH, Søndergaard E, Møller N, Rittig N. Clinical Use of Hypertonic Lactate—Current Evidence and Emerging Perspectives. The Journal of Clinical Endocrinology & Metabolism. 2025;110(9):e2845-e2851. doi:10.1210/clinem/dgaf321

BibTeX
@article{Pedersen2025,
  author = {Pedersen, Mette Glavind Bülow and Voigt, Jens Hohwü and Søndergaard, Esben and Møller, Niels and Rittig, Nikolaj},
  title = {Clinical Use of Hypertonic Lactate—Current Evidence and Emerging Perspectives},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {9},
  pages = {e2845--e2851},
  doi = {10.1210/clinem/dgaf321}
}
Kostenlos starten →